SLC35A2 and Cirrhosis: Since UGT enzymes contribute to the metabolism of asciminib, for severe HI, a ‘modified Sim-Cirrhosis CP-C’ population, accounting for the reduced activity of UGT2B7 and UGT1A4 in such patients, was also used.